Emerald Health Therapeutics (CVE:EMH) Shares Down 3.8% – Here’s Why

Emerald Health Therapeutics, Inc. (CVE:EMH)’s stock price fell 3.8% during trading on Wednesday . The stock traded as low as C$0.25 and last traded at C$0.26. 384,329 shares were traded during trading, a decline of 40% from the average session volume of 644,760 shares. The stock had previously closed at C$0.27.

Emerald Health Therapeutics Stock Down 3.8%

The company has a market cap of C$52.28 million and a price-to-earnings ratio of -0.37. The company has a debt-to-equity ratio of 35.45, a quick ratio of 2.61 and a current ratio of 2.97. The stock’s fifty day moving average is C$0.26 and its two-hundred day moving average is C$0.26.

Emerald Health Therapeutics Company Profile

Emerald Health Therapeutics, Inc, together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc and changed its name to Emerald Health Therapeutics, Inc in June 2015. Emerald Health Therapeutics, Inc is headquartered in Vancouver, Canada.